Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia

• Bela Patel,
• Amy A. Kirkwood,
• Clare J. Rowntree,
• Krisztina Z. Alapi,
• Emilio Barretta,
• Laura Clifton‐Hadley,
• Tom Creasey,
• SooWah Lee,
• David I. Marks,
• Anthony V. Moorman,
• Nicholas Morley,
• Pip Patrick,
• Zaynab Rana,
• Anita Rijneveld,
• John A. Snowden,
• Adele K. Fielding

Affiliations

Bela Patel

Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK

Amy A. Kirkwood

CR UK and UCL Cancer Trial Centre, UCL Cancer Institute, UCL London UK

Clare J. Rowntree

Cardiff and Vale UHB Cardiff Wales UK

Krisztina Z. Alapi

Hematology, UCL Cancer Institute London UK

Emilio Barretta

Leukemia Research Cytogenetics Group, Translational and Clinical Research Institute Newcastle University Newcastle Upon Tyne UK

Laura Clifton‐Hadley

CR UK and UCL Cancer Trial Centre, UCL Cancer Institute, UCL London UK

Tom Creasey

Leukemia Research Cytogenetics Group, Translational and Clinical Research Institute Newcastle University Newcastle Upon Tyne UK

SooWah Lee

Hematology, UCL Cancer Institute London UK

David I. Marks

United Bristol Healthcare Trust Bristol UK

Anthony V. Moorman

Leukemia Research Cytogenetics Group, Translational and Clinical Research Institute Newcastle University Newcastle Upon Tyne UK

Nicholas Morley

Royal Hallamshire Hospital Sheffield Teaching Hospital NHS Foundation Trust Sheffield UK

Pip Patrick

CR UK and UCL Cancer Trial Centre, UCL Cancer Institute, UCL London UK

Zaynab Rana

CR UK and UCL Cancer Trial Centre, UCL Cancer Institute, UCL London UK

Anita Rijneveld

Erasmus Medical Centre Rotterdam Netherlands

John A. Snowden

Royal Hallamshire Hospital Sheffield Teaching Hospital NHS Foundation Trust Sheffield UK

Adele K. Fielding

Hematology, UCL Cancer Institute London UK